Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Noriko Nishimura

Showing results (41-50 of 84) with videos related to

Pageof 9
Sort By:
Yonago Acta Medica|July 20, 2019
Re-evaluation of Urinary Trypsin Inhibitor on Pregnancy Course in Patients with Threatened Preterm Delivery: A Single-Center Retrospective StudyHiroaki Komatsu, Fuminori Taniguchi, Takashi Harada, et al.
Archives of Toxicology|October 28, 2010
Global DNA methylation in the mouse liver is affected by methyl deficiency and arsenic in a sex-dependent mannerKeiko Nohara, Takashi Baba, Hikari Murai, et al.
Cancer Genetics and Cytogenetics|June 18, 2003
Establishment of a new human malignant fibrous histiocytoma cell line, FU-MFH-1: cytogenetic characterization by comparative genomic hybridization and fluorescence in situ hybridizationJun Nishio, Hiroshi Iwasaki, Masako Ishiguro, et al.
Japanese Journal of Clinical Oncology|March 26, 2014
Rapid progression of anemia related to tumor-lysis syndrome associated with bortezomib treatment in myeloma patientsKazuhito Suzuki, Yasuhito Terui, Noriko Nishimura, et al.
The Journal of Rheumatology|September 11, 2003
Increase of soluble FcgRIIIa derived from natural killer cells and macrophages in plasma from patients with rheumatoid arthritisMidori Masuda, Tadanobu Morimoto, Masja De Haas, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|March 29, 2011
Activation of aryl hydrocarbon receptor induces vascular inflammation and promotes atherosclerosis in apolipoprotein E-/- miceDalei Wu, Noriko Nishimura, Victoria Kuo, et al.
The Journal of Biological Chemistry|August 1, 2002
Apaf-1 is a mediator of E2F-1-induced apoptosisYusuke Furukawa, Noriko Nishimura, Yutaka Furukawa, et al.
Leukemia & Lymphoma|March 10, 2021
Progression-free survival at 24 months as a predictor of survival outcomes after CHOP treatment in patients with peripheral T-cell lymphoma: a single-center validation study in a Japanese populationYuko Shirouchi, Masahiro Yokoyama, Takanori Fukuta, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|November 26, 2011
Prospective evaluation of incidence and severity of oral mucositis induced by conventional chemotherapy in solid tumors and malignant lymphomasNoriko Nishimura, Kenji Nakano, Kyoko Ueda, et al.
Leukemia & Lymphoma|March 16, 2013
Prognostic value of high thymidine kinase activity in patients with previously untreated diffuse large B-cell lymphoma treated by rituximab, cyclophosphamide, doxorubicin, vincristine and prednisoloneKazuhito Suzuki, Yasuhito Terui, Masahiro Yokoyama, et al.
Pageof 9

Showing results (41-50 of 84) with videos related to

Sort By:
Pageof 9
Yonago Acta Medica|July 20, 2019
Re-evaluation of Urinary Trypsin Inhibitor on Pregnancy Course in Patients with Threatened Preterm Delivery: A Single-Center Retrospective StudyHiroaki Komatsu, Fuminori Taniguchi, Takashi Harada, et al.
Archives of Toxicology|October 28, 2010
Global DNA methylation in the mouse liver is affected by methyl deficiency and arsenic in a sex-dependent mannerKeiko Nohara, Takashi Baba, Hikari Murai, et al.
Cancer Genetics and Cytogenetics|June 18, 2003
Establishment of a new human malignant fibrous histiocytoma cell line, FU-MFH-1: cytogenetic characterization by comparative genomic hybridization and fluorescence in situ hybridizationJun Nishio, Hiroshi Iwasaki, Masako Ishiguro, et al.
Japanese Journal of Clinical Oncology|March 26, 2014
Rapid progression of anemia related to tumor-lysis syndrome associated with bortezomib treatment in myeloma patientsKazuhito Suzuki, Yasuhito Terui, Noriko Nishimura, et al.
The Journal of Rheumatology|September 11, 2003
Increase of soluble FcgRIIIa derived from natural killer cells and macrophages in plasma from patients with rheumatoid arthritisMidori Masuda, Tadanobu Morimoto, Masja De Haas, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|March 29, 2011
Activation of aryl hydrocarbon receptor induces vascular inflammation and promotes atherosclerosis in apolipoprotein E-/- miceDalei Wu, Noriko Nishimura, Victoria Kuo, et al.
The Journal of Biological Chemistry|August 1, 2002
Apaf-1 is a mediator of E2F-1-induced apoptosisYusuke Furukawa, Noriko Nishimura, Yutaka Furukawa, et al.
Leukemia & Lymphoma|March 10, 2021
Progression-free survival at 24 months as a predictor of survival outcomes after CHOP treatment in patients with peripheral T-cell lymphoma: a single-center validation study in a Japanese populationYuko Shirouchi, Masahiro Yokoyama, Takanori Fukuta, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|November 26, 2011
Prospective evaluation of incidence and severity of oral mucositis induced by conventional chemotherapy in solid tumors and malignant lymphomasNoriko Nishimura, Kenji Nakano, Kyoko Ueda, et al.
Leukemia & Lymphoma|March 16, 2013
Prognostic value of high thymidine kinase activity in patients with previously untreated diffuse large B-cell lymphoma treated by rituximab, cyclophosphamide, doxorubicin, vincristine and prednisoloneKazuhito Suzuki, Yasuhito Terui, Masahiro Yokoyama, et al.
Pageof 9